These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 2502901

  • 1. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR.
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [Abstract] [Full Text] [Related]

  • 2. Determination of candidates for adjunctive 'gastroprotective' prostaglandins.
    Adelizzi RA.
    J Am Osteopath Assoc; 1990 Jul; 90(7):598-601. PubMed ID: 2115860
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of misoprostol in upper gastro-intestinal lesions in arthritic patients on non-steroidal anti-inflammatory drugs (NSAIDS)--an Indian experience.
    Bhatt CB, Pipalia DH, Naik SR, Tilve GH.
    J Postgrad Med; 1988 Oct; 34(4):224-8. PubMed ID: 3151214
    [No Abstract] [Full Text] [Related]

  • 4. Preventing NSAID-induced ulcers: the use of misoprostol.
    Lynn MM, Holdcroft C.
    Nurse Pract; 1990 Oct; 15(10):38-9, 42. PubMed ID: 2122334
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G, Hopkins A, Akbar FA.
    Postgrad Med J; 1988 Oct; 64 Suppl 1():60-77. PubMed ID: 3138682
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The use of misoprostol in prevention of gastric disease from nonsteroidal anti-inflammatory drugs in oral-maxillofacial surgery].
    Bocca M, Giordano M, Del Pizzo M, Nelken A, Ghiggia M, Pomatto E.
    Minerva Ortognatod; 1990 Oct; 8(2):139-41. PubMed ID: 2126183
    [Abstract] [Full Text] [Related]

  • 9. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE.
    Postgrad Med J; 1988 Oct; 64 Suppl 1():7-11. PubMed ID: 3138683
    [Abstract] [Full Text] [Related]

  • 10. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 11. [Prostaglandin analogues in ulcer disease].
    Malmquist J.
    Ugeskr Laeger; 1989 Apr 17; 151(16):1005. PubMed ID: 2502876
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS, Stead H, Wallemark CB, Nicholson PA.
    J Rheumatol Suppl; 1991 Mar 17; 28():11-4. PubMed ID: 1903808
    [Abstract] [Full Text] [Related]

  • 13. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
    Saggioro A, Alvisi V, Blasi A, Dobrilla G, Fioravanti A, Marcolongo R.
    Ital J Gastroenterol; 1991 Mar 17; 23(3):119-23. PubMed ID: 1742504
    [Abstract] [Full Text] [Related]

  • 14. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
    Lanza F, Peace K, Gustitus L, Rack MF, Dickson B.
    Am J Gastroenterol; 1988 Feb 17; 83(2):143-6. PubMed ID: 3124604
    [Abstract] [Full Text] [Related]

  • 15. [Prostaglandins and the prevention of non-steroidal antirheumatic drug-induced gastric lesions].
    Miederer SE.
    Fortschr Med; 1989 Mar 30; 107(10):63-4, 67-8. PubMed ID: 2497057
    [Abstract] [Full Text] [Related]

  • 16. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 30; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 17. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin.
    Roth S, Agrawal N, Mahowald M, Montoya H, Robbins D, Miller S, Nutting E, Woods E, Crager M, Nissen C.
    Arch Intern Med; 1989 Apr 30; 149(4):775-9. PubMed ID: 2495779
    [Abstract] [Full Text] [Related]

  • 18. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
    Cibere J, Sibley JT, Haga M.
    J Rheumatol; 2002 Feb 30; 29(2):339-46. PubMed ID: 11838854
    [Abstract] [Full Text] [Related]

  • 19. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM, Saggioro A.
    J Rheumatol Suppl; 1991 Mar 30; 28():15-8. PubMed ID: 1674754
    [Abstract] [Full Text] [Related]

  • 20. Non-steroidal anti-inflammatory drugs.
    Fenn C, Shield M.
    Ir Med J; 1990 Mar 30; 83(1):40-1. PubMed ID: 2113895
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.